IDEXX Laboratories, Inc. (IDXX) Q3 2016 Earnings Results

IDEXX Labs Beats on EPS, Stock Down 2.95%

IDEXX Labs reported a better-than-expected EPS, but the stock fell by nearly 3% in response. Investors may be concerned about the lack of revenue details and future guidance. The cautious tone from management could also have contributed to the stock's decline.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.62	N/A	+4.73%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management conveyed a positive outlook on the company's core operations. However, they acknowledged some market challenges.

Management highlighted strong performance in key product lines.

They expressed confidence in long-term growth despite current challenges.

IDEXX Labs Beats on EPS, Stock Down 2.95%

Key numbers

Management commentary

IDEXX Laboratories, Inc.

More earnings this week

IDEXX Labs Beats on EPS, Stock Down 2.95%

Key numbers

Management commentary